ABSTRACT: The post-surgery integrity of the tendons and muscle quality are the two major factors in success of rotator cuff (RC) repair. Though surgical techniques for rotator cuff repair have significantly improved in the past two decades, there are no effective treatments to improve tendon-to-bone healing and muscle quality after repair at this point in time. Pulsed electromagnetic fields (PEMF) have previously been used for promoting fracture healing. Previous studies have shown that PEMF has a positive role in promoting osteoblast precursors proliferation and differentiation. However, PEMFs effect on tenocytes and muscle cells has not been determined fully yet. The purpose of this study is to define the role of a commercially available PEMF on tenocytes and myoblasts growth and differentiation in vitro. Human rotator cuff tenocytes and C2C12 murine myoblasts were cultured and treated with PEMF for 2 weeks under regular and inflammatory conditions. Our results showed that 2 weeks treatment of PEMF enhanced gene expressions of growth factors in human rotator cuff tenocytes under inflammatory conditions. PEMF significantly enhanced C2C12 myotube formation under normal and inflammatory conditions. Results from this study suggest that PEMF has a positive role in promoting tenocyte gene expression and myoblast differentiation. Therefore, PEMF may potentially serve as a non-operative treatment to improve clinical incomes rotator cuff tendon repairs. 
Rotator cuff tears are extremely common shoulder injuries. The prevalence of full-thickness rotator cuff (RC) tears is reported as 21% in the general population and increases considerably with aging.
1 Surgical repair for torn tendons remains the most definitive treatment option for symptomatic RC tears when conservative management fails. In US alone, 75,000 patients undergo rotator cuff surgery annually. 2 Small and medium sized tears are amenable to surgical repair, while massive tears often cause significant impairment of shoulder function, and have worse surgical incomes. 3 Outcomes following surgical repair are predicated on both tendon healing and improved muscle function. Clinical studies have demonstrated that the integrity of the tendons and muscle quality following repair are the two major factors in success of rotator cuff repair. 1, 4 Secondary, pathological changes of rotator cuff muscles following RC tears include muscle atrophy [5] [6] [7] and fatty infiltration, [8] [9] [10] [11] which result in decreased joint function even after successful tendon repairs. The presence of these changes in RC muscles have been correlated with higher rates of re-tear following intervention. More importantly, the development of muscle atrophy and degeneration after RC tears is often thought to be clinically irreversible. 5, [12] [13] [14] [15] [16] Though surgical techniques for RC repair have significantly improved in the past two decades, there are still no effective treatments to improve muscle quality after RC tears surgical repair. Further, despite improved biomechanical constructs, there are few solutions for biologically improving tendon to bone healing for RC repairs.
Pulsed electromagnetic field (PEMF) therapy, a safe biophysical adjunct treatment, has been demonstrated to have beneficial therapeutic effects on a variety of bone related disorders. The FDA has approved several PEMF devices, which provide a complementary solution to spinal fusions 17, 18 in addition to improving healing of non-unions and delayed unions. 19 Though the detailed mechanism is not fully understood, previous studies have shown that PEMF promotes osteoblast precursor proliferation and differentiation, [20] [21] [22] as well as stem cell osteogenesis. 23, 24 The success of PEMF in promoting bone healing has boosted the enthusiasm of expanding its use for treating other tissue injuries. Recent studies have shown positive effect of PEMF in promoting wound healing and cartilage repair. 25, 26 Recently, Osti et al. reported a randomized controlled trial with patients undergoing rotator cuff repair which showed that the application of pulsed electromagnetic fields after rotator cuff repair is safe and reduces postoperative pain, analgesic use, and stiffness in the short term. 27 However, the underline mechanism of the effect of various PEMF on rotator cuff tendon and muscle remains unknown. In this study, we examined the effect of Physio-Stim may suggest a role for PEMF in improving outcomes after RC repair.
MATERIALS AND METHODS
Human Rotator Cuff Tenocyte Harvest Rotator cuff tissue was harvested from one healthy 19-year-old male donor obtained from Allosource Inc. (Centennial, CO). The donor's supraspinatus tendon was dissected into 5 mm Â 5 mm pieces. Explants of tissue were then plated in sterile Falcon TM tissue culture dishes (Fisher Scientific Inc., Pittsburgh, PA) and cultured in standard cell culture media (DMEM with 10% fetal bovine serum and 1% antibiotic-antimycotic) at 37˚C in a humidified atmosphere containing 5% CO 2 . Tenocytes were allowed to expand from the explants and were collected when reaching 80% confluence. Tenocytes were then passaged for three to five passages before being plated into 6-well Falcon TM tissue culture plates with a density of 320,000 cells/well.
Myoblast Culture C2C12 murine myoblasts (American Type Culture Collection, Rockville, MD) were seeded at a density of 160,000 cells/well in 6-well Falcon TM tissue culture plates. The C2C12 cells were cultured with standard cell culture media (DMEM with 10% fetal bovine serum and 1% antibiotic-antimycotic) at 37˚C in a humidified atmosphere containing 5% CO 2 .
Simulating Inflammatory Condition With IL-1 To simulate the inflammatory conditions, the cells were cultured with standard medium supplemented with 10 ng/ml interleukin(IL)-1a (R&D system, Minneapolis, MN) as described previously. 28 The medium was changed every other day with freshly made IL-1a containing medium. For all experiments, cells were cultured for 1 and 2 weeks without passaging.
PEMF Treatment
The 6-well Falcon TM tissue culture plates containing tenocytes or myoblasts were placed in the center of CO 2 incubator equipped with a Physio-Stim 1 PEMF system (Orthofix Inc., Lewisville, TX). Cells were exposed to PEMF for 3 h a day throughout the experiment. Cells in the control group were placed in the same incubator with the PEMF system turned off.
Cell Viability
Cell viability was analyzed using the LIVE/DEAD Viability/Cytotoxicity kit (Life Technologies Inc. Carlsbad, CA Germany). C2C12 myogenesis was determined by fusion index, which was calculated by dividing the total number of nuclei within multinucleated myotubes by the total number of nuclei as described previously. 29 Eight replicates per condition were counted. Images were reviewed and fusion index was the average of calculation made by two independent reviewers who were blinded to the experiment.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
Total RNA for both tenocytes and myobytes was isolated using Trizol reagent (Life Technology, Inc.) according to manufacturer's instructions. cDNA was synthesized using Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Bioscience, Indianapolis, IN). Real-time PCR was performed to quantify the expression of interested genes using SYBR Green Detection and an Applied Biosystems Prism 7900HT detection system (Applied Biosystems, Inc., Foster City, CA). Genes and sequences of the primers used for myoblasts and tenocytes were summarized in Tables 1  and 2 , respectively. Gene expression level was normalized to the internal control of S26 for myoblasts and GAPDH for tenocytes. Fold changes relative to non-PEMF controls were calculated using DDC T .
Statistical Analysis
All results were presented as mean AE standard deviation. T-test was used for comparison between PEMF treated and no PEMF treated control groups in each condition at each time point. Significant difference was considered when p < 0.05. Myogenin  TTA CGT CCA TCG TGG ACA GC  TGG GCT GGG TGT TAG CCT TA  RPS26 CGG AAC ATT GTA GAA GCC GCT G CCT TGC TAT GGA TGG CAC AGC T 
PEMF up-Regulated Myogenic Gene Expression
In standard medium, 1 week of PEMF treatment did not alter the expression level of myogenic genes in C2C12 cells compared to non PEMF treatment control. However, prolonged treatment of PEMF for 2 weeks significantly increased myomaker and myosin heavy chain 1 (MHC1) gene expression levels by 2.3-and 4.7-folds, respectively in C2C12 myoblasts compared to control groups (p < 0.05 for both genes) (Fig. 3) . Under inflammatory condition (10 ng/ml of IL-1 in standard medium), PEMF regulates C2C12 myoblast gene expression with a different pattern. Similar to that in standard medium, 1 week treatment of PEMF did not alter the expression level of key myogenesis genes in C2C12 cells. However, prolonged treatment of PEMF for 2 weeks significantly increased MyoD expression for 9.4-fold (p < 0.05), but did not alter the expression level of myomaker or MHC1 expression compared to the control (Fig. 4) .
PEMF Increased Myotube Formation
Histology demonstrated more myotubes formed by C2C12 myoblasts in standard medium in the PEMFtreated group compared to the control group (Fig. 5) . After 1 week, the fusion index was 76.25 AE 1.20% in the PEMF-treated group and 67.75 AE 3.32% in the control group. At 2 weeks, the fusion index for PEMF group is 94.00 AE 1.41% and 82.25 AE 2.76% in the control group. At both time points, PEMF significantly PEMF MYOBLAST TENOCYTE increased myotube fusion index in C2C12 myoblasts compared to the control group (p < 0.05) (Fig. 5B) . The effect of PEMF on C2C12 myotube formation was more significant when the cells were treated with IL-1. Under pro-inflammatory conditions (10 ng/ml of IL-1), the fusion index was 23.0 AE 6.9% in the PEMF-treated group and 6.7 AE 3.9% in the control group. At 2 weeks, the fusion index for PEMF group is 72.9 AE 11.0% and 37.2 AE 10.2% in the control group (Fig. 6) . At both time points, PEMF significantly increased myotube fusion index in C2C12 (p < 0.05) ( Figure 6B ).
PEMF Increased Tenocyte Gene Expressions Under Inflammatory Condition
Under standard culture condition, PEMF did not significantly change the expression of any genes tested in tenocytes at either 1 or 2 weeks after treatment (Fig. 7) . However, under inflammatory conditions (10 ng/ml of IL-1), PEMF treatment significantly increased the gene expression of collagen I (2.9-fold) at 1 week and growth factors of TGFb-1 (3.5-fold), PDGFb (6.3-fold), and BMP12 (3.0-fold), as well as TIMP4 (5.1-fold) at 2 weeks in human rotator cuff tenocytes (p < 0.05) (Fig. 8) . 
DISCUSSION
The goal of this in vitro study was to examine the effect of Physio-Stim
1
, an FDA-approved PEMF, on the viability and differentiation of primary human rotator cuff tenocytes and a myoblast cell line. We hypothesized that PEMF would be safe technique to enhance tenocyte and myoblast viability and differentiation. We found that PEMF did not jeoparize tenocyte and myoblast cell viability at both time points examined. We found that PEMF resulted in a marked increase in myotube formation with a concomitant rise in pro-myogenic gene expression. Although PEMF did not stimulate tenocyte gene expression under normal conditions, it did increase the factors associated with tenocyte growth and differentiation in inflammatory conditions which may mimic the postoperative state.
Tendon disorders are common and are responsible for morbidity in many orthopedic patients. Tendon healing can occur intrinsically, via proliferation of epitenon, and endotenon tenocytes. Internal tenocytes contribute to the intrinsic repair process by secreting collagen fibers and stimulating tendon to bone healing. 30 The effect of PEMF on tendon repair is not well investigated, and previous reports have demonstrated contradictory results. [31] [32] [33] [34] These controversial findings may be due to in part to the disparate source of tenocytes. Thus, we used primary human rotator cuff tenocytes in this study.
In this in vitro study, treatment with PEMF did not significant alter gene expression of collagens, extracellular matrix components, growth factors, MMPs, and other molecules in standard culture medium. Our results are consistent with a previous study using primary cultured tenocytes from human supraspinatus and quadriceps tendons, in which PEMF was found to have no effect on tenocyte growth, cell cycle, and total collagen accumulation. 35 This suggests that our current PEMF signal may not have a substantial role in stimulating RC tenocyte gene expression under the normal culture condition.
However, when tenocytes are cultured in a pro-inflammatory environment, PEMF significantly promoted gene expression of type I collagen, certain growth factors, including TGF-b, PDGFb, and BMP-12 (also known as Growth differentiation factor 7, GDF7) and TIMP-4, an important regulator of a group of extracellular matrix remodeling enzymes-matrix metalloproteinases (MMPs) in tenocytes. Previous studies have also showed that although PEMF had no effect on tenocyte growth and collagen accumulation, it significantly accelerated tenocyte healing after injury. 35 This interesting result suggests that tenocytes cultured under different physiological conditions react to PEMF in different way. Though PEMF has minimal effect on gene expression of tenocytes cultured in standard media, it has a beneficial role in promoting their gene expressions under an inflammatory condition. Given the pro-inflammatory post-surgical state, this provides preliminary data suggesting that PEMF may have a beneficial role in stimulating factors associated with tendon to bone healing in a post-surgical state.
Large and massive rotator cuff tears are usually accompanied with muscle atrophy and degeneration. However, there is no effective treatment for these muscle changes at this time. A myoblast is an embryonic progenitor cell that differentiates to muscle cells in a process known as myogenesis. 36 Though myoblast proliferation and fusion into myofibers usually happens during developmental stage, recent studies suggest it can still occur in the adult following injury or other more subtle stresses. [36] [37] [38] Promotion of myogenesis of myoblasts and their derivatives, including satellite cells, may therefore be a promising countermeasure for muscle atrophy and degeneration after RC tears. 39 In our study, we tested the role of PEMF on myoblast myogenesis. Our result demonstrated that PEMF increased fusion index of myoblast 2-5-folds compared to non-treated controls under both standard and inflammatory conditions. Though the underlining mechanism of PEMF function remains undiscovered, this result suggests that PEMF may serve as non-invasive treatment to promote muscle regeneration during RC repair, as well as after other muscle injuries.
Our finding that PEMF promotes C2C12 myogenesis is consistent with a previous study with a dualmode electric and magnetic biological stimulator (EM-Stim). In this study, the authors found that combined electric and magnetic fields accelerated myogenic differentiation of myoblasts into myotubes. 40 Electric and magnetic fields are both present with PEMF. However, it remains unknown which is more important in promoting myogenesis. Future studies are needed to fully discover the mechanism of PEMF-induced myogenesis of myoblasts, and to determine other important factors such as exposure duration and field strength in optimizing these promising early results.
Inflammation has been proven to be an important factor in tendon to bone healing. However, the effect of inflammation on rotator cuff muscle degeneration after RC tears remains unclear. Previous studies have demonstrated the presence of macrophages in RC muscle after tendon tears in both human and animal studies. 41, 42 Furthermore, inhibition of 5-LOX, COX-1, and COX-2 increases tendon healing and reduces muscle degeneration after RC repair in rats. 43 These results suggest that inflammation also plays an important role the development of secondary muscle pathological changes after RC tears. Interestingly, PEMF was more effective in promoting C2C12 myogenesis under inflammatory conditions compared to standard culture conditions. This data suggests that PEMF may be more suitable to treat muscle atrophy and degeneration associated with inflammation.
There are several limitations of this study. First, only one PEMF treatment strategy (daily treatment with 3 h a day) was tested in this study. This is the same strategy currently FDA approved for PEMF to treat fracture non-unions. However, the optimal treatment time and frequency of PEMF to treat non-union may be different from that to treat RC tears. Future work is needed to test different PEMF strategies on muscle and tendon cells. Secondly, the primary cultured human tenocytes used in this study were cultured for third to fifth passage before experiments. Previous study suggests that tenocytes from human Achilles tendon start to lose partial phenotype as early as the third passage, 44, 45 Though possible phenotype drift of cultured rotator cuff tenocytes has not been demonstrated up to date, it is possible that the cultured rotator cuff tenocytes may possess slightly different phenotype than those in situ. Thirdly, we only evaluated the role of PEMF on gene expression of tenocytes and myoblasts. Future work should explore the cellular and molecular mechanisms by evaluating the protein expression level that govern the changes that occur due to PEMF, as this understanding will help delineate the use of PEMF clinically. Last but not least, only in vitro experiments were included in this study. Future in vivo animal studies are clearly needed to fully evaluate the role of PEMF in treating RC tears.
In summary, our findings in this study suggest that PEMF has a significant effect on myoblasts and tenocytes, and could potentially serve as a safe and effective measure to promote tendon integrity and muscle regeneration after rotator cuff injuries.
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